Shukra Pharmaceuticals Limited, a active public limited company, was established on 04 March 1993 in Ahmedabad, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: L24231GJ1993PLC019079. Registered under ROC Roc Ahmedabad. it is listed on BSE: 524632. It has an authorized capital of ₹49.00 Cr and a paid-up capital of ₹43.79 Cr.
Formerly known as Relish Pharmaceuticals Private Limited, Relish Pharmaceuticals Limited. It upholds a compliant status. In 2024, it reported revenue of ₹77.39 Cr and a net worth of ₹57.64 Cr. Employing 99 professional, Its leadership includes Payal Sujay Mehta (Director), Jitendra Somchand Shah (Director), Ritu Kapoor (Director). Past directors included Sujay Jyotindra Mehta, Payal Sujay Mehta, Jitendra Somchand Shah. It holds ₹8.83 Cr open charges and ₹15.92 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 3Rd Floor, Dev House, Opp. Wiaa Office, Judges Bungalows Road,, Bodakdev,, Ahmedabad, Gujarat, 380003.
L24231GJ1993PLC019079
019079
04 March 1993
₹49.00 Cr
₹43.79 Cr
Roc Ahmedabad
Listed (BSE: 524632)
Active
Explore comprehensive insights into Shukra Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Payal Sujay Mehta | Director | 23 May 2012 | Current |
| Jitendra Somchand Shah | Director | 10 Jul 2024 | Current |
| Ritu Kapoor | Director | 25 Oct 2024 | Current |
| Sonal Deepalbhai Gandhi | Director | 12 Aug 2023 | Current |
| Bhoomiben Patel | Director | 16 Jan 2019 | Current |
| Dakshesh Rameshchandra Shah | Managing Director | 26 May 2012 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Cfo(Kmp) | 13 Feb 2019 | Past |
| Pramod Abcsdd | Additional Director | 28 Sep 2012 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
| Pramod Abcsdd | Additional Director | 05 Mar 2025 | Past |
| Pramod Abcsdd | Additional Director | 21 Sep 2023 | Past |
| Pramod Abcsdd | Ceo(Kmp) | 31 Mar 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Shukra Pharmaceuticals Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 28.91% increase. The company also saw a substantial improvement in profitability, with a 320.68% increase in profit. The company's net worth Soared by an impressive increase of 127.85%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Shukra Pharmaceuticals had a promoter holding of 50.95% and a public holding of 49.04%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹88,269,000.00
₹159,201,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Aug 2025 | Others | ₹2.89 M | Open |
| 06 Aug 2025 | Others | ₹2.88 M | Open |
| 06 Sep 2024 | Others | ₹6.00 Cr | Open |
| 16 Dec 2022 | Tata Capital Financial Services Limited | ₹7.50 M | Open |
| 28 Dec 2020 | Tata Capital Financial Services Limited | ₹1.50 Cr | Open |
Explore comprehensive loan charge details -
Shukra Pharmaceuticals has a workforce of 99 employees as of Mar 26, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Shukra Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shukra Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Others amounted to Rs. 0.29 Cr with Charge ID 101144979 was registered on 24 Aug 2025. was recorded as a recent event.
A charge with Others amounted to Rs. 0.29 Cr with Charge ID 101144794 was registered on 06 Aug 2025. was recorded as a recent event.
Progress on Ritu Kapoor was appointed as a Director was appointed as a Director on 25 Oct 2024 & has been associated with this company since 1 year 1 month . was documented.
The activity Shital Dakshesh Shah was appointed as a Whole-time director was appointed as a Whole-time director on 25 Oct 2024 & has been associated with this company since 1 year 1 month . was completed.
Progress on Shukra Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
A charge with Others of Rs. 6.00 Cr registered on 06 Sep 2024 with Charge ID 100970269 was modified on 13 Sep 2024. was recorded as a recent event.
The CIN of Shukra Pharmaceuticals Limited is L24231GJ1993PLC019079.
Shukra Pharmaceuticals Limited is headquartered at 3Rd Floor, Dev House, Opp. Wiaa Office, Judges Bungalows Road,, Bodakdev,, Ahmedabad, Gujarat, 380003.
Shukra Pharmaceuticals Limited was incorporated on 04 March 1993.
The current directors of Shukra Pharmaceuticals Limited are
The primary industry of Shukra Pharmaceuticals Limited is Manufacturing.
Shukra Pharmaceuticals Limited is listed. It is listed on BSE: 524632.
The authorized capital of Shukra Pharmaceuticals Limited is ₹49.00 Cr, and the paid-up capital is ₹43.79 Cr.
The compliance status of Shukra Pharmaceuticals Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX